Teva Stock Highest Level: Why It Could Soar Further
Teva is shifting from a debt-laden generic player to a branded-focused pharma with a stronger balance sheet. This piv...
We compare Which Dividend Aristocrats Etf Did Best In 2024, spotlighting performance leaders and factors behind stronger returns.
22,900 articlesTeva is shifting from a debt-laden generic player to a branded-focused pharma with a stronger balance sheet. This piv...
U.S. stocks fell as bond yields climbed, pushing the Nasdaq Composite lower and underscoring renewed risk-off trading...
Bitcoin slips below the $80,000 level, dragging ripple (xrp) and solana (sol) lower as yields rise and hedging pressu...
Ethereum slides to its yearly low against Bitcoin as traders move ETH to exchanges, signaling rising selling pressure...
Bitcoin slid to a two-week low near $78,000 after a brief run to the mid-80s, throwing cold water on a quick bear-mar...
Crypto traders are watching SpaceX’s near-public listing for signs that pre-IPO perpetual futures could become a majo...
Ken Griffin, the Citadel founder once openly skeptical of AI, has pivoted to embracing its potential, telling audienc...
As large pharma hunts for GLP-1 and cardiovascular assets, three biotechs stand out as hot takeover targets. This rep...
The SEC is preparing to unveil an innovation exemption to pilot tokenized stock exemption equities on crypto rails, i...
A regional Amazon-like player in LATAM sits near its 52-week low. This article breaks down why MercadoLibre stands ou...
Astera Labs’ stock jumped after management laid out a firm timetable for a new switch and signaled growing opportunit...
A Buffett-inspired AI model forecasts XRP price paths through 2026, with a base around $2.50 and an all-time high nea...